Literature DB >> 11201000

[Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee].

G Horneff1, J Forster, H W Seyberth, H Michels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11201000     DOI： 10.1007/s003930070043

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  8 in total

1.  [Biologics for treatment of juvenile idiopathic arthritis. Consensus statement of the 7th Wörlitzer Expertengespräche 2004 for the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie].

Authors:  G Horneff
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 2.  [Importance of the new biologicals and cytokine antagonists in the treatment of juvenile idiopathic arthritis (JIA)].

Authors:  G Horneff
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

3.  Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.

Authors:  Tim Niehues; Gerd Horneff; Hartmut Michels; Michaela Sailer Höck; Lothar Schuchmann
Journal:  Rheumatol Int       Date:  2005-02-02       Impact factor: 2.631

Review 4.  [The importance of biologicals in the treatment of SoJIA].

Authors:  G Dückers; T Niehues
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

5.  Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept.

Authors:  M Halbig; G Horneff
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

Review 6.  The German etanercept registry for treatment of juvenile idiopathic arthritis.

Authors:  G Horneff; H Schmeling; T Biedermann; I Foeldvari; G Ganser; H J Girschick; T Hospach; H I Huppertz; R Keitzer; R M Küster; H Michels; D Moebius; B Rogalski; A Thon
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

7.  [Psoriasis und Psoriasis arthritis in childhood and adolescence. Overview and consensus statement of the 9th Wörlitz Expert Round Table Discussion 2006 for the Society for Child and Adolescent Rheumatology].

Authors:  M Sticherling; K Minden; R-M Küster; A Krause; M Borte
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

8.  Education and employment in patients with juvenile idiopathic arthritis - a standardized comparison to the German general population.

Authors:  Jenny Schlichtiger; Johannes-Peter Haas; Swaantje Barth; Betty Bisdorff; Lisa Hager; Hartmut Michels; Boris Hügle; Katja Radon
Journal:  Pediatr Rheumatol Online J       Date:  2017-05-22       Impact factor: 3.054
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.